Pentamidine salts useful in the treatment of pneumocystis carinii pneumonia
Patent 5084480 Issued on January 28, 1992. Estimated Expiration Date: 
July 19, 2009. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
July 19, 2009. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 2204983 2277861 2277862 2410796 2424325 2425223 2449724 3105853 Bis-(meta-amidinophenoxy)-compounds and pharmacologically acceptable acid addition salts thereof Aromatic amidines as antiviral agents in animals InventorsAssigneeApplicationNo. 383243 filed on 07/19/1989US Classes:514/554, Amine addition salt of the acid562/587, Polyoxy562/589Lactic acid per se or salt thereofExaminersPrimary: Gray, BruceAttorney, Agent or FirmForeign Patent References
International ClassA61K 031/205AbstractSalts of pentamidine, formulations containing such salts and the use of such salts of treatment or prophylaxis of pneumocystis carinii. Pentamidine gluconate and lactate has been discovered and found to have high water solubility while providing potentially less toxic alternatives to pentamidine isethionate, especially for aerosolized administration to patients suffering from acquired immunodeficiency syndrome, AIDS, or AIDS related complex, ARC.Other References
|
| ||||||||||||||
